Michael Woudenberg - Oct 18, 2021 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
VP, Chem/Manufacturing/Control
Signature
/s/ Bruce Colwill, attorney-in-fact for Mr. Michael Woudenberg
Stock symbol
INM
Transactions as of
Oct 18, 2021
Transactions value $
$0
Form type
4
Date filed
10/19/2021, 06:23 PM
Next filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +30K +49.13% $0.00 91.1K Oct 18, 2021 Common shares 30K $1.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.